MET Tyrosine Kinase Inhibition Enhances the Antitumor Efficacy of an HGF Antibody.
Farrell, P.J., Matuszkiewicz, J., Balakrishna, D., Pandya, S., Hixon, M.S., Kamran, R., Chu, S., Lawson, J.D., Okada, K., Hori, A., Mizutani, A., Iwata, H., de Jong, R., Hibner, B., Vincent, P.(2017) Mol Cancer Ther 16: 1269-1278
- PubMed: 28341789 
- DOI: 10.1158/1535-7163.MCT-16-0771
- Primary Citation of Related Structures:  
5UAB, 5UAD, 6UBW - PubMed Abstract: 
Receptor tyrosine kinase therapies have proven to be efficacious in specific cancer patient populations; however, a significant limitation of tyrosine kinase inhibitor (TKI) treatment is the emergence of resistance mechanisms leading to a transient, ...